Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Globe Newswire • about 2 months agoNOVATO, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...